Liquidia (LQDA) Gross Profit (QoQ) (2021 - 2026)
Liquidia (LQDA) Gross Profit (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Liquidia | 7.62 Bn | 7.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.17% |
| Dec 31, 2025 | 66.93% |
| Sep 30, 2025 | 589.82% |
| Jun 30, 2025 | 370.68% |
| Mar 31, 2025 | 2.56% |
| Dec 31, 2024 | -45.79% |
| Sep 30, 2024 | 33.10% |
| Jun 30, 2024 | 43.92% |
| Mar 31, 2024 | -57.46% |
| Dec 31, 2023 | 13.84% |
| Sep 30, 2023 | -24.47% |
| Jun 30, 2023 | 7.19% |
| Mar 31, 2023 | -17.72% |
| Dec 31, 2022 | 92.41% |
| Sep 30, 2022 | -23.91% |
| Jun 30, 2022 | 13.90% |
| Mar 31, 2022 | 12.41% |
| Dec 31, 2021 | 8.74% |
| Sep 30, 2021 | -14.01% |
| Jun 30, 2021 | 11.38% |